Drugs / Alogenic adipose tissue-derived stem cells
Alogenic adipose tissue-derived stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04280003 | Jan 2021 → Jul 2023 | ischemic stroke | Instituto de Investigación Hospital Universitario La Paz | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alogenic adipose tissue-derived stem cells | “Alogenic adipose tissue-derived stem cells” NCT04280003 ↗ |
| Modality | Cell therapy | “alogenic adipose tissue-derived mesenchymal stem cells” NCT04280003 ↗ |
| Route | Intravenous | “intravenous alogenic adipose tissue-derived stem cells” NCT04280003 ↗ |